Lecture #13 Flashcards

1
Q

Graft

A

Transplanted tissue/ organ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ortotopic transplantation

A

The graft is placed in its normal anatomical position

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Heterotrophic tranplantation

A

The graft is placed not in its normal anatomic position

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Isograft/ syngraft

A

The donor and the recipient are homozygotic tweens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Autograft

A

The donor and the recipient are the same person

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Allograft

A

The donor and the recipient are different persons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Xenograft

A

The donor is an animal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Primary rejection of an allograft Ex skin allograft

A

10-14 days

The tissue establishes blood supply (angiogenesis) - immune cells are infiltrated - thrombosis - ischemia - necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Secondary rejection of an allograft Ex skin allograft

A

5-6 days
The tissue already has blood supply therefore infiltration of immune cells is rapid so does thrombus - ischemia and necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Critical matching criteria between donor and recipient

A
  1. Major histocompetability complex
    mainly HLD-A HLA-B HLA-DR
  2. Minor histocompetability molecules
    H-Y on the Y chromosome, HA1-HA5 autosomal peptideson HSC
  3. ABO Rh blood groups, VEC vascular endothelial cells antigen system, SK Skjelbred antigen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Liver transplantation survival rates

A

1y survival over 75%

5y survival 70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Heart transplantation

A

We preform heart transplant only if the patient has more then 50% to die in the present year
5y survival is 80% after 5y CHD will develope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pancreas transplantation

A

1y survival 72% but improves along with kidney transplantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cornea transplantation

A

60-70% acceptance

HLA matching is not prerequisite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Direct alloreactivity

A
  1. Sensitization - the donor’s APCs will go to the lymph nodes and present their self antigen to T cells
  2. Rejection - activated lymphocytes (all types) will reach the organ via blood circulation and attack it (humoral and cytotoxic)

ACUTE and intense

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indirect alloreactivity

A
  1. Sensitization - the recipient’s APCs will engolf antigns from the transplanted tissue and present them to T cells in the lymph nodes
  2. Rejection - activated lymphocytes (mainly Th1 and B cells) will reach the organ via blood circulation and produce Ab against the antigens (humoral mainly)

CHRONIC and mild

17
Q

3 types of HVG reactions (in solid organs)

A
  1. Hyperacute - Preformed Ab against antigens of the donor due to previous exposure to ABO, HLA, VEC antigens
    Ex: pregnancy, abortion, blood transfusion, previous organtransplantation
    The mechanism of rejection is humoral (vasculitis)
  2. Acute - Can be humoral (vasculitis) or cellular (parenchymal damage)
  3. Chronic - mediated by Th1 and macrophages - granuloma formation - fibrosis - loss of activitiy of the organ
18
Q

How do we prevent transplantation rejection?

A
  1. Donor selection
  2. In vitro graft manipulation - elimination of the donor’s immunocompetent cells by steroid infusion/ tolerance induction/ anti CD28/ anti CD4/ anti MHCII…
  3. Immunosuppression of the recipient by anti IL2R, anti TCR, abatacept, GCS (inhibit cytokine production)
19
Q

What are the conditions to development of GVHR?

A
  1. Presence of immunocompetent cells in the graft
    (bone marrow, thymus, spleen, neonatal blood transfusion but also liver, lung, gut)
  2. Impaired imune defense of the recipient
  3. Different HLA genes or minor histocompetability molecules
20
Q

In GVHR the damage to the recipient cells is via

A

Apoptosis

Fas-FasL , TNF, granzymes and perforins